Deep multiple instance learning for predicting chemotherapy response in non-small cell lung cancer using pretreatment CT images

被引:0
|
作者
Runsheng Chang
Shouliang Qi
Yanan Wu
Qiyuan Song
Yong Yue
Xiaoye Zhang
Yubao Guan
Wei Qian
机构
[1] Northeastern University,College of Medicine and Biological Information Engineering
[2] Northeastern University,Key Laboratory of Intelligent Computing in Medical Image, Ministry of Education
[3] Shengjing Hospital of China Medical University,Department of Radiology
[4] Shengjing Hospital of China Medical University,Department of Oncology
[5] The Fifth Affiliated Hospital of Guangzhou Medical University,Department of Radiology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The individual prognosis of chemotherapy is quite different in non-small cell lung cancer (NSCLC). There is an urgent need to precisely predict and assess the treatment response. To develop a deep multiple-instance learning (DMIL) based model for predicting chemotherapy response in NSCLC in pretreatment CT images. Two datasets of NSCLC patients treated with chemotherapy as the first-line treatment were collected from two hospitals. Dataset 1 (163 response and 138 nonresponse) was used to train, validate, and test the DMIL model and dataset 2 (22 response and 20 nonresponse) was used as the external validation cohort. Five backbone networks in the feature extraction module and three pooling methods were compared. The DMIL with a pre-trained VGG16 backbone and an attention mechanism pooling performed the best, with an accuracy of 0.883 and area under the curve (AUC) of 0.982 on Dataset 1. While using max pooling and convolutional pooling, the AUC was 0.958 and 0.931, respectively. In Dataset 2, the best DMIL model produced an accuracy of 0.833 and AUC of 0.940. Deep learning models based on the MIL can predict chemotherapy response in NSCLC using pretreatment CT images and the pre-trained VGG16 with attention mechanism pooling yielded better predictions.
引用
收藏
相关论文
共 50 条
  • [31] Predicting Early Chemotherapy Response with Technetium-99m Methoxyisobutylisonitrile SPECT/CT in Advanced Non-Small Cell Lung Cancer
    Tzu-I J. Yang
    Tjeerd S. Aukema
    Harm van Tinteren
    Sjaak Burgers
    Renato Valdés Olmos
    Marcel Verheij
    [J]. Molecular Imaging and Biology, 2010, 12 : 174 - 180
  • [32] Unsupervised Deep Learning for Clustering Tumor Subcompartments Histopathological Images in Non-Small Cell Lung Cancer
    Oliveira Baffa, Matheus de Freitas
    Schaadt, Nadine Sarah
    Feuerhake, Friedrich
    Deserno, Thomas M.
    [J]. IMAGING INFORMATICS FOR HEALTHCARE, RESEARCH, AND APPLICATIONS, MEDICAL IMAGING 2024, 2024, 12931
  • [33] PREDICTING MUTATION STATUS AND RECURRENCE FREE SURVIVAL IN NON-SMALL CELL LUNG CANCER: A HIERARCHICAL CT RADIOMICS - DEEP LEARNING APPROACH
    Patel, Divek
    Cowan, Connor
    Prasanna, Prateek
    [J]. 2021 IEEE 18TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), 2021, : 882 - 885
  • [34] Predicting bone metastasis-free survival in non-small cell lung cancer from preoperative CT via deep learning
    Guo, Jia
    Miao, Jianguo
    Sun, Weikai
    Li, Yanlei
    Nie, Pei
    Xu, Wenjian
    [J]. NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [35] Predicting treatment response in multicenter non-small cell lung cancer patients based on federated learning
    Liu, Yuan
    Huang, Jinzao
    Chen, Jyh-Cheng
    Chen, Wei
    Pan, Yuteng
    Qiu, Jianfeng
    [J]. BMC CANCER, 2024, 24 (01)
  • [36] Predicting early chemotherapy response with 99mTc-MIBI in advanced non-small cell lung cancer
    Yang, Tzu-, I
    Aukema, Tjeerd
    van Tinteren, Harm
    Burgers, Sjaak
    Olmos, Renato Valdes
    Verheij, Marcel
    [J]. CANCER RESEARCH, 2009, 69
  • [37] Discovery of a phosphosignature predicting response to dasatinib in non-small cell lung cancer
    Klammer, Martin
    Kaminski, Marc
    Zedler, Alexandra
    Oppermann, Felix
    Mueller, Stefan
    Tebbe, Andreas
    Whittaker, Mark
    Godi, Klaus
    Schaab, Christoph
    [J]. CANCER RESEARCH, 2012, 72
  • [38] Predicting response of non-small cell lung cancer to the telomerase inhibitor imetelstat
    Frink, Robin E.
    Girard, Luc
    Wright, Woodring E.
    Shay, Jerry W.
    Minna, John D.
    [J]. CANCER RESEARCH, 2011, 71
  • [39] Neoadjuvant chemotherapy in non-small cell lung cancer
    Niklinski, J
    [J]. 8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 217 - 223
  • [40] CHEMOTHERAPY OF NON-SMALL CELL LUNG-CANCER
    MITROU, PS
    KLIPPSTEIN, T
    LAUTENSCHLAGER, G
    [J]. ATEMWEGS-UND LUNGENKRANKHEITEN, 1986, 12 (11) : 544 - 549